Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaëtan Devos

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
European Urology|May 4, 2019
Re: Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without AbirateroneGaëtan Devos, Gert De Meerleer, Charlien Berghen, et al.
European Urology Oncology|May 29, 2021
Is the Age of Extended Pelvic Lymph Node Dissection Over? The Devil Is in the DetailsGaëtan Devos, Andries Clinckaert, Gert De Meerleer, et al.
Cancers|March 6, 2021
Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate CancerWout Devlies, Florian Handle, Gaëtan Devos, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 6, 2021
Benefits and harms of the new prostate cancer grade grouping on the prediction of long-term oncological outcomes in patients after radical prostatectomyDaimantas Milonas, Tim Muilwijk, Zilvinas Venclovas, et al.
European Urology|January 15, 2022
Re: Molecular Features of Exceptional Response to Neoadjuvant Anti-androgen Therapy in High-risk Localized Prostate CancerWout Devlies, Gaëtan Devos, Henri Decloedt, et al.
Journal of Behavioral Addictions|August 10, 2022
An empirical investigation of the Pathways Model of problem gambling through the conjoint use of self-reports and behavioural tasksCéline Bonnaire, Gaëtan Devos, Servane Barrault, et al.
Current Urology|November 23, 2020
Prostate-Specific Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer: a Non-Randomized, Retrospective Observational RegistrationAntonino Battaglia, Gaëtan Devos, Guy Boeckx, et al.
Frontiers in Oncology|October 9, 2023
Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patientsAlexander Giesen, Loïc Baekelandt, Wout Devlies, et al.
Urologic Oncology|June 8, 2021
Radium-223 in patients with prostate specific antigen (PSA) progression and without clinical metastases following maximal local therapy: A pilot studyLorenzo Tosco, Gaëtan Devos, Laura Schillebeeckx, et al.
Ecancermedicalscience|June 23, 2020
Metastasis-directed therapy for oligometastatic urological tumours: still no second-hand newsCharlien Berghen, Steven Joniau, Christof Vulsteke, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
European Urology|May 4, 2019
Re: Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without AbirateroneGaëtan Devos, Gert De Meerleer, Charlien Berghen, et al.
European Urology Oncology|May 29, 2021
Is the Age of Extended Pelvic Lymph Node Dissection Over? The Devil Is in the DetailsGaëtan Devos, Andries Clinckaert, Gert De Meerleer, et al.
Cancers|March 6, 2021
Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate CancerWout Devlies, Florian Handle, Gaëtan Devos, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 6, 2021
Benefits and harms of the new prostate cancer grade grouping on the prediction of long-term oncological outcomes in patients after radical prostatectomyDaimantas Milonas, Tim Muilwijk, Zilvinas Venclovas, et al.
European Urology|January 15, 2022
Re: Molecular Features of Exceptional Response to Neoadjuvant Anti-androgen Therapy in High-risk Localized Prostate CancerWout Devlies, Gaëtan Devos, Henri Decloedt, et al.
Journal of Behavioral Addictions|August 10, 2022
An empirical investigation of the Pathways Model of problem gambling through the conjoint use of self-reports and behavioural tasksCéline Bonnaire, Gaëtan Devos, Servane Barrault, et al.
Current Urology|November 23, 2020
Prostate-Specific Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer: a Non-Randomized, Retrospective Observational RegistrationAntonino Battaglia, Gaëtan Devos, Guy Boeckx, et al.
Frontiers in Oncology|October 9, 2023
Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patientsAlexander Giesen, Loïc Baekelandt, Wout Devlies, et al.
Urologic Oncology|June 8, 2021
Radium-223 in patients with prostate specific antigen (PSA) progression and without clinical metastases following maximal local therapy: A pilot studyLorenzo Tosco, Gaëtan Devos, Laura Schillebeeckx, et al.
Ecancermedicalscience|June 23, 2020
Metastasis-directed therapy for oligometastatic urological tumours: still no second-hand newsCharlien Berghen, Steven Joniau, Christof Vulsteke, et al.
Pageof 6